Your browser doesn't support javascript.
loading
Mortality risk factors and fulminant sub-phenotype in anaerobic bacteremia: a 10-year retrospective, multicenter, observational cohort study.
Nagaoka, Kentaro; Iwanaga, N; Takegoshi, Y; Murai, Y; Kawasuji, H; Miura, M; Sato, Y; Hatakeyama, Y; Ito, H; Kato, Y; Shibayama, N; Terasaki, Y; Fujimura, T; Takazono, T; Kosai, K; Sugano, A; Morinaga, Y; Yanagihara, K; Mukae, H; Yamamoto, Y.
Affiliation
  • Nagaoka K; Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, 2630 Sugitani, Toyama, 930-0194, Japan. knagaoka@med.u-toyama.ac.jp.
  • Iwanaga N; Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.
  • Takegoshi Y; Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, 2630 Sugitani, Toyama, 930-0194, Japan.
  • Murai Y; Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, 2630 Sugitani, Toyama, 930-0194, Japan.
  • Kawasuji H; Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, 2630 Sugitani, Toyama, 930-0194, Japan.
  • Miura M; Department of Infection Control, Toyama Nishi General Hospital, Toyama, Japan.
  • Sato Y; Department of Infection Control, Kamiichi General Hospital, Toyama, Japan.
  • Hatakeyama Y; Department of Infection Control, Takaoka City Hospital, Toyama, Japan.
  • Ito H; Department of Infection Control, Takaoka City Hospital, Toyama, Japan.
  • Kato Y; Department of Infection Control, Toyama City Hospital, Toyama, Japan.
  • Shibayama N; Department of Infection Control, Toyama City Hospital, Toyama, Japan.
  • Terasaki Y; Department of Infection Control, Toyama City Hospital, Toyama, Japan.
  • Fujimura T; Department of Infection Control, Toyama City Hospital, Toyama, Japan.
  • Takazono T; Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.
  • Kosai K; Department of Laboratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.
  • Sugano A; Center for Clinical Research, Toyama University Hospital, Toyama, Japan.
  • Morinaga Y; Department of Microbiology, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan.
  • Yanagihara K; Department of Laboratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.
  • Mukae H; Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.
  • Yamamoto Y; Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, 2630 Sugitani, Toyama, 930-0194, Japan.
Eur J Clin Microbiol Infect Dis ; 43(3): 459-467, 2024 Mar.
Article in En | MEDLINE | ID: mdl-38172403
ABSTRACT

PURPOSE:

During the last decade, the incidence of anaerobic bacteremia (AB) has been increasing. Patients with AB may develop complex underlying diseases, which can occasionally be accompanied by fatal or fulminant outcomes. However, the risk factors for AB-related mortality remain unclear. Herein, we sought to elucidate the risk factors for AB-related mortality.

METHODS:

In this multicenter, retrospective, observational study, we enrolled patients with culture-proven AB from six tertiary hospitals in Japan, between January 2012 and December 2021. Data on patient and infection characteristics, laboratory findings, treatment, and outcome were collected, and their associations with mortality were analyzed.

RESULTS:

A total of 520 participants were included. The 30-day mortality in the study cohort was 14.0% (73 patients), and malignant tumors were frequently observed comorbidities in 48% of the entire cohort. Multivariable logistic regression analysis showed a Charlson comorbidity score of > 6, serum creatinine level of > 1.17 mg/dL, and hypotension to be independent risk factors for 30-day mortality in AB (odds ratios [ORs] 2.12, 2.25, and 5.12, respectively; p < 0.05), whereas drainage significantly reduced this risk (OR, 0.28; p < 0.0001). Twelve patients (2.3% of the whole cohort and 16.4% of the deceased patients) presented with extremely rapid progression leading to fatal outcome, consistent with "fulminant AB."

CONCLUSIONS:

This study identified acute circulatory dysfunction and performance of drainage as independent predictive factors for 30-day AB-related mortality and revealed the existence of a fulminant AB sub-phenotype. Our findings could serve as a practical guide to predict the clinical outcomes of AB.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bacteremia Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Eur J Clin Microbiol Infect Dis / Eur. j. clin. microbiol. infect. dis / European journal of clinical microbiology and infectious diseases Journal subject: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Year: 2024 Document type: Article Affiliation country: Japón Country of publication: Alemania

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bacteremia Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Eur J Clin Microbiol Infect Dis / Eur. j. clin. microbiol. infect. dis / European journal of clinical microbiology and infectious diseases Journal subject: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Year: 2024 Document type: Article Affiliation country: Japón Country of publication: Alemania